Myers Ronald E, Weinberg David S, Manne Sharon L, Sifri Randa, Cocroft James, Kash Kathryn, Wilfond Benjamin
Department of Medical Oncology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Genet Med. 2007 Jun;9(6):378-84. doi: 10.1097/gim.0b013e3180654ce2.
The assessment of genetic variants and environmental exposures (i.e., genetic and environmental risk assessment) may permit individualized risk stratification for common diseases as part of routine care. A pilot study was conducted to assess the uptake of, and response to, testing for colorectal cancer risk among average risk patients in primary care practice settings.
Physicians in primary care practices identified patients eligible for colorectal cancer screening and referred them to the study. Research staff administered a baseline survey to consenting patients. At a scheduled office visit, participants underwent decision counseling with a trained nurse educator to facilitate informed decision making about being tested for methylene tetrahydrofolate reductase status and red blood cell folate level. Combined assessment can stratify colorectal cancer risk. Test results were disclosed within 2 weeks after the visit. Postvisit and 1-month endpoint surveys were administered. Univariable analyses of survey data were performed to assess changes from baseline in genetic and environmental risk assessment and colorectal cancer screening-related knowledge and perceptions.
Of the 57 patients who were referred to the study, 25 (44%) consented to participate, and all but one were tested. Participant knowledge about genetic and environmental risk assessment and colorectal cancer screening, perceived colorectal cancer screening response efficacy, and perceived social support for colorectal cancer screening increased significantly from baseline. Participants reported low levels of intrusive thoughts about CRC.
Knowledge and favorable perceptions of colorectal cancer screening increased, as did knowledge about genetic and environmental risk assessment, after exposure to the study intervention. Further research is needed to assess genetic and environmental risk assessment uptake and impact at the population level.
对基因变异和环境暴露进行评估(即基因和环境风险评估),作为常规医疗的一部分,可能有助于对常见疾病进行个体化风险分层。开展了一项试点研究,以评估初级保健实践环境中平均风险患者对结直肠癌风险检测的接受情况及反应。
初级保健机构的医生识别出符合结直肠癌筛查条件的患者,并将他们转介至该研究。研究人员对同意参与的患者进行了基线调查。在预定的门诊就诊时,参与者与一名经过培训的护士教育工作者进行了决策咨询,以促进关于检测亚甲基四氢叶酸还原酶状态和红细胞叶酸水平的明智决策。综合评估可以对结直肠癌风险进行分层。检测结果在就诊后2周内披露。进行了就诊后和1个月终点调查。对调查数据进行单变量分析,以评估基因和环境风险评估以及与结直肠癌筛查相关的知识和认知从基线起的变化。
在被转介至该研究的57名患者中,25名(44%)同意参与,除一人外均接受了检测。参与者关于基因和环境风险评估以及结直肠癌筛查的知识、对结直肠癌筛查反应效果的认知以及对结直肠癌筛查的社会支持感知均较基线有显著增加。参与者报告对结直肠癌的侵入性想法水平较低。
在接受研究干预后,对结直肠癌筛查的知识和积极认知有所增加,关于基因和环境风险评估的知识也是如此。需要进一步研究以评估在人群层面基因和环境风险评估的接受情况及影响。